Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2096640
18404479
9001
10.1007/s11302-006-9001-7
Original Article


E-NTPDases in human airways: Regulation and relevance for chronic lung diseases

Burch
Lauranell H.

1

Picher
Maryse

pichm@med.unc.edu

2

1
Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, North Carolina USA 
2
Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, University of North Carolina, 7010 Thurston-Bowles Building, Chapel Hill, NC 27599 USA 

30
5
2006

6
2006

2
2
399
408
11
1
2005

21
12
2005


© Springer Science + Business Media B.V. 2006

Pseudomonas aeruginosa
 lipopolysaccharide (LPS), induces an acute reduction in azide-sensitive E-NTPDase activities, followed by a sustained increase in activity as well as NTPDase 1 and NTPDase 3 expression. Accordingly, chronic lung diseases, including cystic fibrosis (CF) and primary ciliary dyskinesia, are characterized by higher rates of nucleotide elimination, azide-sensitive E-NTPDase activities and expression. This review integrates the biphasic regulation of airway E-NTPDases with the function of purine signaling in lung diseases. During acute insults, a transient reduction in E-NTPDase activities may be beneficial to stimulate ATP-mediated bacterial clearance. In chronic lung diseases, elevating E-NTPDase activities may represent an attempt to prevent P2 receptor desensitization and nucleotide-mediated lung damage.

Keywords
apyrase
bacterial clearance
CD39
chrosobstructive lung diseases
diphosphohydrolase
endotoxin
purinergic signaling
oxidative stress

issue-copyright-statement
© Springer Science+Business Media, Inc. 2006




Introduction
1
2
3
4
5
6
7
8
50
50
9
10
1
2A
2B
3
11
4
12
1
3
13
14
].
15
]. This review describes the importance of regulating extracellular nucleotide concentrations for airway homeostasis and the impact of chronic lung diseases on E-NTPDases. Few studies have addressed the activity or expression of airway E-NTPDases. In this review, the available information is complemented by original data.

Nucleotide-mediated bacterial clearance
16
1
17
18
19
16
+
Fig. 1
Impact of chronic obstructive lung diseases on mucociliary clearance. The polarized epithelium is composed of columnar (ciliated or mucin-secreting) cells facing the lumen and basal cells facing the serosal compartment. Bacterial clearance in healthy lungs is maintained by coordinated cilia beating activity within the PCL layer, moving upward the overlying mucus and pathogens. In chronic obstructive lung diseases, cilia are collapsed under a thick layer of mucus containing bacteria and leukocytes.




20
2B
5
−
2+
−
2
2+
2
+
2+
21
−
−
−
22
2
4
5
2+
2+
−
7
22
23
7
 receptors may contribute to disease-associated epithelial damage.
2
24
26
27
28
2
29
16
30
31
32
33
2
6
34
35
36
37
38
].
10
29
39
40
41
2
42
].

P2 receptors and airway inflammation
In vivo
43
43
44
2B
7
2B
7
 receptor expression were decreased, by mechanical ventilation supports a dynamic role for ectonucleotidases in the regulation of purine signaling in the airways.
1
2
45
P. aeruginosa
45
2
46
7
47
1
3
14
7
48
]. Altogether, these studies entail that P2 receptor activation may not only induce innate immunity but also amplify pathogen-induced inflammatory responses in chronic infectious lung diseases.

Too much of a good thing..
49
51
6
2
42
1
3
52
53
7
23
7
54
7
7
2
39
7
22
]. The impact of P2X and P2Y receptor activation on inflammatory responses mediated by airway epithelia under normal and pathological conditions remains to be investigated.

E-NTPDases regulate airway ATP
9
10
55
58
2a
2b
9
59
9
10
15
60
2+
2+
61
62
63
64
65
66
67
3
2b
3
67
m
68
Fig. 2
a
10
b
N
P
 < 0.05; Mann-Whitney test).



Fig. 3
89
N
P
 < 0.05; Mann-Whitney test).




in vitro
6
in vivo
in vitro
69
2
2
70
].
67
71
].

Chronic lung diseases shorten the signals
10
72
4
9
Fig. 4
N
10
N
P
 < 0.05; Mann-Whitney test).




Pseudomonas aeruginosa
51
P. aeruginosa
P. aeruginosa
73
5A
5B
Fig. 5
P. aeruginisa
A
10
B
N
P
 < 0.05; Mann-Whitney test).




74
P aeruginosa
75
76
77
78
79
80
80
5B
79
], the early loss of surface activity may involve local peroxidation of membrane lipids.
81
82
83
73
84
P. aeruginosa
85
86
87
P. aeruginosa
88
P. aeruginosa LPS
 in human airways.

Adaptation of purine signaling to airway diseases
6
P. aeruginosa
P. aeruginosa
Fig. 6
2B
2
4, 5, 7
) responding to higher ATP cocnentrations.




The information provided in this review also exposes the complexity of the signaling interactions taking place between different classes of mediators, including bacterial products, cytokines and extracellular nucleotides, as combinations of mediators may induce different responses than when tested individually. Furthermore, communication networks in the airways may evolve with time during the establishment of a chronic infection, as new target cells (bacteria, leukocytes, lymphocytes) agglomerate on either side of the epithelial barrier. It is proposed that nucleotide-mediated airway functions defined in normal tissues or aseptic culture conditions may require reassessment under conditions mimicking chronic lung diseases before their therapeutic potential may be clearly established.


Acknowledgment
The human nasal and bronchial epithelial cells were provided by the Tissue Culture Core of the Cystic Fibrosis Center (UNC-CH), directed by Dr Scott H. Randell. This work was supported by the Cystic Fibrosis Foundation (Picher 02I0 and Picher 05G0).

References
1.
Pelleg
A.

Schulman
E.


Adenosine 5’-triphosphate axis in obstructive airway diseases
Am J Ther
2002
9
454
464
10.1097/00045391-200209000-00014

12237739


2.
Burnstock
G

Knight
GE.


Cellular distribution and functions of P2 receptor subtypes in different systems
Int Rev Cytol
2004
240
31
304
10.1016/S0074-7696(04)40002-3

15548415


3.
Dubyak
GR


Purinergic signaling at immunological synapses
J Auton Nerv Syst
2000
81
64
68
10.1016/S0165-1838(00)00155-7

10869702


4.
Homolya
L

Steinberg
TH

Boucher
RC


Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia
J Cell Biol
2000
150
1349
1360
10.1083/jcb.150.6.1349

10995440


5.
Huang
P

Lazarowski
ER

Tarran
R



Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells
Proc Natl Acad Sci USA
2001
98
14120
14125
10.1073/pnas.241318498

11707576


6.
Lazarowski
ER

Boucher
RC

Harden
TK


Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules
Mol Pharmacol
2003
64
785
795
10.1124/mol.64.4.785

14500734


7.
Gabriel
SE


Fuller
CM


Calcium-activated Cl-conductance in the airway epithelium
Current Topics in Membranes
2002
San Diego
Elsevier Science
193
207

Gabriel SE (2002) Calcium-activated Cl-conductance in the airway epithelium. In: Fuller CM (ed) Current topics in membranes. San Diego, Elsevier Science, pp 193–207 

8.
Boeynaems
JM

Communi
D

Gonzalez
NS



Overview of the P2 receptors
Semin Thromb Hemost
2005
31
139
149
10.1055/s-2005-869519

15852217


9.
Picher
M

Burch
LH

Hirsh
AJ



Ecto 5’-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways
J Biol Chem
2003
278
13468
13479
10.1074/jbc.M300569200

12560324


10.
Picher
M

Burch
LH

Boucher
RC


Metabolism of P2 receptor agonists in human airways: Implications for mucociliary clearance and cystic fibrosis
J Biol Chem
2004
279
20234
20241
10.1074/jbc.M400305200

14993227


11.
Fredholm
BB


Adenosine receptors as targets for drug development
Drug News Perspect
2003
16
283
289
10.1358/dnp.2003.16.5.829316

12942159


12.
Boucher
RC


New concepts of the pathogenesis of cystic fibrosis lung disease
Eur Respir J
2004
23
146
158
10.1183/09031936.03.00057003

14738247


13.
Greenberg
S

Zhao
X

Wang
J



in vivo

Am J Physiol
1997
273
L967
L979

9374723


14.
Sala
A

Ferrari
D

Virgilio
F



Alerting and tuning the immune response by extracellular nucleotides
J Leukoc Biol
2003
73
339
343
10.1189/jlb.0802418

12629147


15.
Zimmermann
H


Ectonucleotidases: Some recent developments and a note on nomenclature
Drug Dev Res
2001
52
44
56
10.1002/ddr.1097

Zimmermann H (2001) Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res 52:44–56 

16.
Boucher
RC


New concepts of the pathogenesis of cystic fibrosis lung disease
Eur Respir J
2004
23
146
158
10.1183/09031936.03.00057003

14738247


17.
Tarran
R

Boucher
RC


in vitro

Methods Mol Med
2002
70
479
492

11917544


18.
Roomans
GM

Kozlova
I

Nilsson
H



Measurements of airway surface liquid height and mucus transport by fluorescence microscopy, and of ion composition by X-ray microanalysis
J Cyst Fibros
2004
3
Suppl 2
135
139
10.1016/j.jcf.2004.05.029

15463946


19.
Tarran
R


Regulation of airway surface liquid volume and mucus transport by active ion transport
Proc Am Thorac Soc
2004
1
42
46
10.1513/pats.2306014

16113411


20.
Gabriel
SE

Boucher
RC


Crystal
RG

West
JB


Ion channels
The Lung
1997
Philadelphia
Lippincott-Raven
205
318

Gabriel SE, Boucher RC (1997) Ion channels. In: Crystal RG, West JB (eds) The lung. Philadelphia, Lippincott-Raven, pp 205–318 

21.
Mall
M

Wissner
A

Gonska
T



+
 absorption by extracellular nucleotides in human normal and cystic fibrosis airways
Am J Respir Cell Mol Biol
2000
23
755
761

11104728


22.
Taylor
AL

Schwiebert
LM

Smith
JJ



Epithelial P2X purinergic receptor channel expression and function
J Clin Invest
1999
104
875
884
10.1172/JCI7270

10510328


23.
Adinolfi
E

Pizzirani
C

Idzko
M



7
 receptor: Death or life?
Purin Signal
2005
1
219
227
10.1007/s11302-005-6322-x

Adinolfi E, Pizzirani C, Idzko M et al (2005) P2X7 receptor: Death or life? Purin Signal 1:219–27 

24.
Wong
LB

Yeates
DB


Luminal purinergic regulatory mechanisms of tracheal ciliary beat frequency
Am J Respir Cell Mol Biol
1992
7
447
454

1389212


25.
Evans
JH

Sanderson
MJ


Intracellular calcium oscillations regulate ciliary beat frequency of airway epithelial cells
Cell Calcium
1999
26
103
110
10.1054/ceca.1999.0060

10598274


26.
Morse
DM

Smullen
JL

Davis
CW


Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells
Am J Physiol
2001
280
C1485
C1497

Morse DM, Smullen JL, Davis CW (2001) Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells. Am J Physiol 280:C1485–97 

27.
Davis
C


in vitro
 cellular models
Novartis Found Symp
2002
248
113
125
10.1002/0470860790.ch8

12568491


28.
Conway
JD

Bartolotta
T

Abdullah
LH

Davis
CW


Regulation of mucin secretion from human bronchial epithelial cells grown in murine hosted xenografts
Am J Physiol
2003
284
L945
L954

Conway JD, Bartolotta T, Abdullah LH, Davis CW (2003) Regulation of mucin secretion from human bronchial epithelial cells grown in murine hosted xenografts. Am J Physiol 284:L945–54 

29.
Tarran
R

Grubb
BR

Parsons
D



In vivo
 observations and therapeutic approaches
Mol Cell
2001
8
149
158
10.1016/S1097-2765(01)00286-6

11511368


30.
Polosa
R

Rorke
S

Holgate
ST


Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease
Thorax
2002
57
649
654
10.1136/thorax.57.7.649

12096211


31.
Berge
M

Polosa
R

Kerstjens
HAM



The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease
J Allergy Clin Immunol
2004
114
737
746
10.1016/j.jaci.2004.05.071

15480309


32.
Basoglu
OK

Pelleg
A

Essilfie-Quaye
S



Effects of aerosolized adenosine 5’-triphosphate vs adenosine 5’-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma
Chest
2005
128
1905
1909
10.1378/chest.128.4.1905

16236834


33.
Pellegrino
R

Wilson
O

Jenouri
G



Lung mechanics during induced bronchoconstriction
J Appl Physiol
1996
81
964
975

8872669


34.
Sabater
JR

Mao
YM

Shaffer
C



2
-receptor agonists enhances mucociliary clearance in sheep
J Appl Physiol
1999
87
2191
2196

10601167


35.
Bennett
WD

Zeman
KL

Foy
C



Effect of aerosolized uridine 5’-triphosphate on mucociliary clearance in mild chronic bronchitis
Am J Respir Crit Care Med
2001
164
302
306

11463605


36.
Bennett
WD

Olivier
KN

Zeman
KL



Effect of uridine 5’-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis
Am J Respir Crit Care Med
1996
153
1796
1801

8665037


37.
Olivier
KN

Bennett
WD

Hohneker
KW



Acute safety and effects on mucociliary clearance of aerosolized uridine 5’-triphosphate +/− amiloride in normal human adults
Am J Respir Crit Care Med
1996
154
217
223

8680683


38.
Noone
PG

Bennett
WD

Regnis
JA



Effect of aerosolized uridine-5’-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia
Am J Respir Crit Care Med
1999
160
144
149

10390392


39.
Yerxa
BR

Sabater
JR

Davis
CW



2
 receptor agonist for the treatment of cystic fibrosis
J Pharmacol Exp Ther
2002
302
871
880
10.1124/jpet.102.035485

12183642


40.
Kellerman
D

Evans
R

Mathews
D

Shaffer
C


2
 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
Adv Drug Deliv Rev
2002
54
1463
1474
10.1016/S0169-409X(02)00154-0

12458155


41.
Deterding
R

Retsch-Bogart
G

Milgram
L



2
 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
Pediatr Pulmonol
2005
39
339
348
10.1002/ppul.20192

15704203


42.
Clarke
LL

Harline
MC

Otero
MA



2
 receptor-activated transepithelial anion secretion
Am J Physiol Cell Physiol
1999
276
C777
C787

Clarke LL, Harline MC, Otero MA et al (1999) Desensitization of P2Y2 receptor-activated transepithelial anion secretion. Am J Physiol Cell Physiol 276:C777–87 

43.
Rich
PB

Douillet
CD

Mahler
SA



Adenosine triphosphate is released during injurious mechanical ventilation and contributes to lung edema
J Trauma
2003
55
290
297
10.1097/01.TA.0000078882.11919.AF

12913640


44.
Douillet
CD

Robinson
WP
III

Zarzaur
BL



Mechanical ventilation alters airway nucleotides and purinoceptors in lung and extrapulmonary organs
Am J Respir Cell Mol Biol
2005
32
52
58
10.1165/rcmb.2004-0177OC

15388514


45.
Pseudomonas aeruginosa
. Am J Physiol 289:L890–5

46.
Ribeiro
CMP

Paradiso
AM

Schwab
U



2+
 independent hyperinflammatory response in human cystic fibrosis airway epithelia
J Biol Chem
2005
280
17798
17806
10.1074/jbc.M410618200

15746099


47.
Denlinger
LC

Fisette
PL

Sommer
JA



7
 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide
J Immunol
2001
167
1871
1876

11489964


48.
Perregaux
DG

McNiff
P

Laliberte
R



ATP Acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood
J Immunol
2000
165
4615
4623

11035104


49.
Brown
EA

Hoffmann
SP


Update in pulmonary medicine
Clin Pediatr Med Surg
2002
19
1
22
10.1016/S0891-8422(03)00078-8

Brown EA, Hoffmann SP (2002) Update in pulmonary medicine. Clin Pediatr Med Surg 19:1–22 

50.
Boucher
RC


Relationship of airway epithelial ion transport to chronic bronchitis
Proc Am Thorac Soc
2004
1
66
70
10.1513/pats.2306018

16113415


51.
Sadikot
RT

Blackwell
TS

Christman
JW

Prince
AS


Pseudomonas aeruginosa
 pneumonia
Am J Respir Crit Care Med
2005
171
1209
1223
10.1164/rccm.200408-1044SO

15695491


52.
North
RA

Surprenant
A


Pharmacology of cloned P2X receptors
Ann Rev Pharmacol Toxicol
2000
40
563
580
10.1146/annurev.pharmtox.40.1.563

10836147


53.
Otero
M

Garrad
R

Velazquez
B



2
 nucleotide receptor
Mol Cell Biochem
2000
205
115
123
10.1023/A:1007018001735

10821429


54.
Kucher
BM

Neary
JT


Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes
J Neurochem
2005
92
525
535
10.1111/j.1471-4159.2004.02885.x

15659223


55.
Picher
M

Boucher
RC


Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways
Am J Respir Cell Mol Biol
2000
23
255
261

10919994


56.
Donaldson
SH

Lazarowski
ER

Picher
M



Basal nucleotide levels, release, and metabolism in normal and cystic fibrosis airways
Mol Med
2000
6
969
982

11147574


57.
Lazarowski
ER

Boucher
RC

Harden
TK


Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations
J Biol Chem
2000
275
31061
31068
10.1074/jbc.M003255200

10913128


58.
Donaldson
SH

Picher
M

Boucher
RC


Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces
Am J Respir Cell Mol Biol
2002
26
209
215

11804872


59.
Fortuna
R

Anderson
HC

Carty
RP

Sajdeja
SW


Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine epiphyseal cartilage
Calcif Tissue Int
1980
30
217
225
10.1007/BF02408631

6772288


60.
Zimmermann
H


Extracellular metabolism of ATP and other nucleotides
Naunyn-Schmiedeberg’s Arch Pharmacol
2000
362
299
309
10.1007/s002100000309

Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg’s Arch Pharmacol 362:299–309 

61.
Plesner
L


Ecto-ATPases: Identities and functions
Int Rev Cytol
1995
158
141
214
10.1016/S0074-7696(08)62487-0

7721538


62.
Leal
DBR

Streher
CA

Neu
TN



Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes
Biochim Biophys Acta
2005
1721
9
15

15652174


63.
Smith
TM

Kirley
TL


Cloning, sequencing and expression of a human brain ecto-apyrase related to both the ecto-ATPase and CD39 ecto-apyrase 1
Biochim Biophys Acta
1998
1386
65
78

9675246


64.
Shi
XJ

Knowles
AF


Prevalence of the mercurial-sensitive ectoATPase in human small cell lung carcinoma: Characterization and partial purification
Arch Biochem Biophys
1994
315
177
184
10.1006/abbi.1994.1487

7979396


65.
Sevigny
J

Robson
SC

Waelkens
E



Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase
J Biol Chem
2000
275
5640
5647
10.1074/jbc.275.8.5640

10681547


66.
Chadwick
BP

Frischauf
AM


Drosophila melanogaster

Genomics
1998
50
357
367
10.1006/geno.1998.5317

9676430


67.
Picher
M

Button
B

Boucher
R


Therapeutic potential of ebselen for nucleotide-mediated mucociliary clearance in the lungs of cystic fibrosis patients
Pediatr Pulmonol
2005
28
274

Picher M, Button B, Boucher R (2005) Therapeutic potential of ebselen for nucleotide-mediated mucociliary clearance in the lungs of cystic fibrosis patients. Pediatr Pulmonol 28:274. 

68.
Kukulski
F

Levesque
SA

Lavoie
EG



Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and 8
Purin Signal
2005
1
193
204
10.1007/s11302-005-6217-x

Kukulski F, Levesque SA, Lavoie EG et al (2005) Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and 8. Purin Signal 1:193–204 

69.
Button
B

Picher
M

Lazarowski
E

Boucher
RC


Sustained release and accumulation of nucleotides during cyclic compressive stress increases mucus clearance in CF human airway epithelial surfaces
Pediatr Pulmonol
2004
27
213

Button B, Picher M, Lazarowski E, Boucher RC (2004) Sustained release and accumulation of nucleotides during cyclic compressive stress increases mucus clearance in CF human airway epithelial surfaces. Pediatr Pulmonol 27:213 

70.
App
EM

Kieselmann
R

Reinhardt
D



Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: Flutter vs autogenic drainage
Chest
1998
114
171
177
10.1378/chest.114.1.171

9674466


71.
Rosenfeld
M

Ramsey
B

Gibson
R


Pseudomonas
 acquisition in young patients with cystic fibrosis: Pathophysiology, diagnosis and management
Curr Opin Pulm Med
2003
9
492
497
10.1097/00063198-200311000-00008

14534401


72.
Picher
M

Burch
LH

Boucher
RC


Expression of alkaline phosphatase and ecto 5’-nucleotidase (CD73) in normal and CF airway epithelia
Pediatr Pulmonol
2000
21
227

Picher M, Burch LH, Boucher RC (2000) Expression of alkaline phosphatase and ecto 5’-nucleotidase (CD73) in normal and CF airway epithelia. Pediatr Pulmonol 21:227 

73.
Picher
M

Boucher
RC


Pseudomonas aeruginosa
 lipopolysaccharide in human airways: An inflammatory response mediated by non-specific alkaline phosphatase
Pediatr Pulmonol
2003
Suppl. 25
271

Picher M, Boucher RC (2003) Detoxification of Pseudomonas aeruginosa lipopolysaccharide in human airways: An inflammatory response mediated by non-specific alkaline phosphatase. Pediatr Pulmonol Suppl. 25:271 

74.
MacNee
W


Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease
Proc Am Thorac Soc
2005
2
50
60
10.1513/pats.200411-056SF

16113469


75.
Rochelle
LG

Fischer
BM

Adler
KB


in vitro

Free Radic Biol Med
1998
24
863
868
10.1016/S0891-5849(97)00375-4

9586818


76.
Zinchuk
VS

Okada
T

Seguchi
H


Lipopolysaccharide alters ecto-ATP-diphosphohydrolase and causes relocation of its reaction product in experimental intrahepatic cholestasis
Cell Tissue Res
2001
304
103
109
10.1007/s004410000339

11383876


77.
Faas
M

Schuiling
G

Valkhof
N



Superoxide-mediated glomerulopathy in the endotoxin-treated pregnant rat
Kidney Blood Press Res
1998
21
432
437
10.1159/000025896

9933828


78.
Krotz
F

Sohn
HY

Keller
M



Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase
Arterioscler Thromb Vasc Biol
2002
22
2003
2009
10.1161/01.ATV.0000043454.08172.51

12482826


79.
Candinas
D

Koyamada
N

Miyatake
T



Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions
Thromb Haemost
1996
76
807
812

8950794


80.
Robson
SC

Kaczmarek
E

Siegel
JB



Loss of ATP diphosphohydrolase activity with endothelial cell activation
J Exp Med
1997
185
153
164
10.1084/jem.185.1.153

8996251


81.
Kalmar
B

Kittel
A

Lemmens
R



Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis
Neurochem Int
2001
38
453
461
10.1016/S0197-0186(00)00090-5

11222926


82.
Kapojos
JJ

Poelstra
K

Borghuis
T



Induction of glomerular alkaline phosphatase after challenge with lipopolysaccharide
Int J Exp Pathol
2003
84
135
144
10.1046/j.1365-2613.2003.00345.x

12974943


83.
Okada
T

Zinchuk
VS

Seguchi
H


Lipopolysaccharide administration increases acid and alkaline phosphatase reactivity in the cardiac muscle
Microsc Res Tech
2002
58
421
426
10.1002/jemt.10156

12226812


84.
Braun
N

Zhu
Y

Krieglstein
J



Up-regulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat
J Neurosci
1998
18
4891
4900

9634555


85.
Pier
GB

Grout
M

Zaidi
TS


Pseudomonas aeruginosa
 from the lung
Proc Natl Acad Sci
1997
94
12088
12093
10.1073/pnas.94.22.12088

9342367


86.
Schroeder
TH

Lee
MM

Yacono
PW



Pseudomonas aeruginosa
 LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation
Proc Natl Acad Sci
2002
99
6907
6912
10.1073/pnas.092160899

11997458


87.
Kikuchi
T

Hagiwara
K

Honda
Y



Clarithromycin
 suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-{kappa}B transcription factors
J Antimicrob Chemother
2002
49
745
755
10.1093/jac/dkf008

12003967


88.
Pier
GB


Pseudomonas aeruginosa
 lung infection
Curr Opin Microbiol
2002
5
81
86
10.1016/S1369-5274(02)00290-4

11834374


89.
Voynow
JA

Fischer
BM

Malarkey
DE



Neutrophil elastase induces mucus cell metaplasia in mouse lung
Am J Physiol
2004
287
L1293
L1302

Voynow JA, Fischer BM, Malarkey DE et al (2004) Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol 287:L1293–302 


Abbreviations
ADP
adenosine 5’-diphosphate


AMP
adenosine 5’-monophosphate


ATP
adenosine 5’-triphosphate


ASL
airway surface liquid


MCC
mucociliary clearance


CCS
cyclic compressive stress


CF
cystic fibrosis


CFTR
cystic fibrosis transmembrane regulator


ENAC
epithelial sodium channel


IL-1β
interleukin-1beta


IL-8
interleukin-8


LPS
lipopolysaccharide


MCC
mucociliary clearance


NS AP
non-specific alkaline phosphatase


PCL
periciliary liquid


PCR
polymerase chain reaction


TNFα
tumor necrosis factor alpha


UTP
uridine 5’-triphosphate






